US Stocks
/
Greenwich LifeSciences, Inc. Share Price

Greenwich LifeSciences, Inc. Share Price

NASDAQ: GLSI | Micro Cap
$15.83
-$2.61 (-14.15%) Last updated on 29 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Greenwich LifeSciences, Inc. Stock Performance

Open
$18.89
Prev. Close
$18.44
Circuit Range
N/A
Day Range
$14.61 - $18.89
Year Range
$7.83 - $33.91
Volume
4,939
Average Traded
$15.64

Greenwich LifeSciences, Inc. Share Price Today

As of 29 August 2026, Greenwich LifeSciences, Inc.'s share price is $15.83. The stock opened at $18.89, compared to its previous close of $18.44. During today's trading session, Greenwich LifeSciences, Inc.'s share price traded between $14.61 and $18.89, with an average price of $16.75. Over the past 52 weeks, the stock has recorded a high of $33.91 and a low of $7.83. In terms of performance, Greenwich LifeSciences, Inc.'s share price has declined by 43.40% over the last six months and is up 38.86% on a year-on-year basis.

Greenwich LifeSciences, Inc. Share Price Chart

$14.61$18.89
L
Show Current Price
H

Greenwich LifeSciences, Inc. Stock Fundamentals & Key Indicators

Market Cap
$206.02M
PE Ratio (TTM)
-13.08
Dividend Yield
N/A
EPS (TTM)
$-1.21
Revenue (TTM)
N/A
Return On Equity (TTM)
-623.07%
Profit Margin
N/A
Debt to Equity
0.62
Quarterly Earnings Growth YoY
-55.57%

Greenwich LifeSciences, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$2.47M-$2.61M-$2.67M-$3.26M-$4.03M-$4.15M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A-5.40%-2.38%-22.09%-23.54%-3.14%

Greenwich LifeSciences, Inc. Annual Profit & Loss

All figures in USD

Particulars202220232024
RevenueN/AN/AN/A
Net Profit-$7.83M-$8.89M-$15.79M
Net Profit MarginN/AN/AN/A
Income ChangeN/A-13.63%-77.57%

About Greenwich LifeSciences, Inc.

Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. Greenwich LifeSciences, Inc. was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. The company was incorporated in 2006 and is headquartered in Stafford, Texas.

Greenwich LifeSciences, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$13.75
$18.44
+39.27%
Jul 2026
$24.27
$13.24
-43.95%
Jun 2026
$28.11
$23.62
-10.67%
May 2026
$24.32
$26.44
+13.38%
Apr 2026
$24.38
$23.32
-2.91%
Mar 2026
$27.99
$24.02
-14.12%
Feb 2026
$30.65
$27.97
-5.44%
Jan 2026
$20.55
$29.58
+39.27%
Dec 2025
$8.60
$21.24
+144.14%
Nov 2025
$8.91
$8.70
-5.33%
Oct 2025
$9.98
$9.19
-6.51%
Sep 2025
$11.72
$9.83
-13.77%

GLSI Share Price FAQs

What is Greenwich LifeSciences, Inc. share price today?

chevron-up
Greenwich LifeSciences, Inc. share price today is $15.83 as on August 29, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Greenwich LifeSciences, Inc. stock?

chevron-up
The 52 week high of Greenwich LifeSciences, Inc. stock is $33.91, while the 52 week low is $7.83 as of 29 Aug '26.

What is GLSI's market capitalisation today?

chevron-up
GLSI market capitalisation is $206.02M as of August 29, 2026, at 10:22 pm IST.

What is GLSI's net income for the last quarter?

chevron-up
GLSI's net income for the last quarter is -0.00B USD.

What is the 5 year returns of GLSI?

chevron-up
The 5 year returns of GLSI is -60.44% as on 29 Aug '26.

What is the high & low stock price of GLSI today?

chevron-up
GLSI stock price hit a high of $18.89 and low of $14.61 as of 29 Aug '26.

Can I buy GLSI shares in India?

chevron-up
Yes. You can buy GLSI in India by opening an international trading account.